MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0065263
Septem Pharmaceuticals Private Limited
Septem Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹55,462
▼ 96% YoY
Net loss · FY 2025
₹3.13 Lakh
Latest filing
EBITDA · FY 2025
-₹3.13 Lakh
Latest filing
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Septem Pharmaceuticals Private Limited
Data last updated:
Septem Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2018PTC103674. Its GSTIN is 09ABACS2358F1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Meraj Ahmad and Suhail Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 61A K No. 254/2 Govind Vihar Kamta Chinhat, Lucknow, Uttar Pradesh, India – 227105.
As per the financials filed for FY 2025, the company reported a revenue of ₹55,462, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹3.13 Lakh and EBITDA of -₹3.13 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 87% over three years and 17% over five years.
Septem Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0065263).
Company details
CIN U24304UP2018PTC103674
Registration Number 103674
Incorporation Date 26 April 2018
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0065263
Key People
Meraj Ahmad Director Suhail Ahmad Director Recognitions & Rankings of Septem Pharmaceuticals
Contact details
Septem Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH. No. 61A K No. 254/2 Govind Vihar Kamta Chinhat, Lucknow, Uttar Pradesh, India – 227105
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Septem Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Septem Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Septem Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Septem Pharmaceuticals Private Limited, buy the company report.
Financials of Septem Pharmaceuticals Private Limited
FY 2025 filings availableSeptem Pharmaceuticals Private Limited reported revenue of ₹55,462 (down 96% YoY) for FY 2025.
Revenue · FY 2025
₹55,462 ▼ 96%
Net loss · FY 2025
₹3.13 Lakh
EBITDA · FY 2025
-₹3.13 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 96%
3 years · compounded
▼ 87%
5 years · compounded
▼ 17%
EBITDA CAGR growth
3 years · compounded
▼ 41%
5 years · compounded
▼ 34%
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 96% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Septem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Septem Pharmaceuticals Private Limited
Septem Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meraj Ahmad | Director | 26 Apr 2018 | 8 Years 6 Months | Current |
| Suhail Ahmad Also directs: Septem Healthcare LLP, Tahira Hospitals Private Limited | Director | 26 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Septem Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Willcure Pharmaceuticals Private Limited | ₹56,037 (FY 2025) | -21.0% | Ghaziabad, Uttar Pradesh, India | |||
| Scafell Pharmaceuticals Private Limited | ₹55,745 (FY 2022) | -72.0% | Jharoda Majra, Delhi, India | |||
| Septem Pharmaceuticals Private Limitedthis company | ₹55,462 (FY 2025) | -₹3.13 Lakh | -96.0% | Lucknow, Uttar Pradesh, India | ||
| Knitlife Pharmaceuticals Private Limited | ₹55,319 (FY 2024) | -91.0% | Delhi, India |
To see the full peer comparison of Septem Pharmaceuticals Private Limited, buy the company report.
Auditor
Septem Pharmaceuticals Private Limited is audited by MANEESH K. GUPTA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANEESH K. GUPTA & CO. | FY 2023 | 005431C |
Shareholding
The shareholding of Septem Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Septem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Septem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Septem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Septem Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABACS2358F1ZD | Uttar Pradesh | Active | 16 Jul 2018 |
To see the full GST registrations and return filing status of Septem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Septem Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Meraj Ahmad was appointed as Director on 26 Apr 2018.
AGM
Septem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Septem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Meraj Ahmad was appointed as Director.
Appointed
Suhail Ahmad was appointed as Director.
Incorporation
26 Apr 2018
Septem Pharmaceuticals Private Limited was registered on 26 Apr 2018 with Roc Kanpur & aged 8 years 6 months as per MCA records.
Frequently asked questions
Septem Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 April 2018 (8+ years old) and is registered under CIN U24304UP2018PTC103674.
Septem Pharmaceuticals has 2 current directors:
- Meraj Ahmad - Director
- Suhail Ahmad - Director
The latest financial statements of Septem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Septem Pharmaceuticals is 09ABACS2358F1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Septem Pharmaceuticals is U24304UP2018PTC103674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Septem Pharmaceuticals was incorporated on 26 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Septem Pharmaceuticals by revenue are Willcure Pharmaceuticals Private Limited, Scafell Pharmaceuticals Private Limited, Knitlife Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (retail trading).
Meraj Ahmad was appointed as Director on 26 Apr 2018. Suhail Ahmad was appointed as Director on 26 Apr 2018.
Yes, Septem Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0065263).
The registered office of Septem Pharmaceuticals is at H. No. 61A K No. 2542 Govind Vihar Kamta Chinhat, Lucknow, Uttar Pradesh, India – 227105.
Septem Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.